Biocon's interchangeable biosimilar Insulin glargine added on Express Scripts ’ largest formulary in US

The listing is expected to boost Biocon's biosimilar business, as inclusion of Semglee on Express Scripts' NPF will allow pharmacies to substitute the much cheaper Semglee for Sanofi's Lantus without having to consult the prescribing healthcare professional.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news